Top Short-Term Stock Picks for 25–29 Aug 2025 | Cohance, Divi’s, Lupin, Mazdock & More
By CapitalKeeper | Short-Term Stock | Indian Equities | Market Moves That Matter
Explore the best short-term stock picks for the week of 25–29 August 2025. Expert analysis on Cohance Lifesciences, Divi’s Labs, Lupin, Uno Minda, Mazdock, and breakout midcap stocks.
📈 Short-Term Stock Picks for the Week (25th – 29th August 2025): Pharma, Defence & Midcaps in Focus
Discover the top short-term stock picks for the week of 25th–29th August 2025. Expert analysis on Cohance Lifesciences, Divi’s Labs, SAI Life, Uno Minda, Lupin, Mazdock, and breakout midcap momentum stocks.
📰 Introduction
The Indian equity market continues to be a stock-pickers’ paradise with sectoral rotations creating opportunities for short-term traders and positional investors. The week of 25th–29th August 2025 looks especially interesting for pharma, speciality chemicals, auto ancillaries, and defence stocks, supported by strong earnings momentum, FII buying in select names, and multiple breakout patterns visible on the charts.
Here’s a detailed intra-week buy call list curated with technical levels, brokerage targets, and momentum-based setups that traders can keep on their radar.
🔹 1. Cohance Lifesciences (COHA)
- CMP: ₹897
- Target: ₹1,150 (Jefferies), ₹1,365 (ICICI Securities)
- Stop-Loss: ₹840–₹850
Analysis:
Cohance Lifesciences has attracted significant institutional attention after recent brokerage coverage. With strong fundamentals in the specialty chemicals and pharma outsourcing segment, the company is well positioned to benefit from export tailwinds and domestic capacity expansion.
Technical Setup:
- The stock has broken out of a long consolidation zone near ₹870.
- Sustaining above ₹890 confirms bullish momentum.
- Indicators such as RSI near 62 and rising volumes support further upside.
Outlook: Short-term traders can accumulate with a target of ₹1,150, while swing traders can hold for ₹1,365.
🔹 2. Divi’s Laboratories (DIVISLAB)
- CMP: ₹6,314
- Target: ₹7,750 (Citi), ₹6,384 (Consensus)
- Stop-Loss: ₹6,050
Analysis:
Divi’s Labs remains one of the most stable pharma bets, with analysts revising their targets upwards after improving guidance and recovery in custom synthesis business. Global demand for APIs is expected to boost earnings in the coming quarters.
Technical Setup:
- Weekly charts show a strong base around ₹6,050–6,100.
- The stock has reclaimed 20-day and 50-day moving averages, showing trend reversal.
- Momentum oscillators suggest room for upside till ₹6,700–6,800 initially.
Outlook: The risk-reward looks attractive for a short-term move toward ₹6,700–6,800 with positional targets of ₹7,750.
🔹 3. SAI Life Sciences
- CMP: ₹943
- Target: ~30% upside (Jefferies’ initiation coverage)
- Stop-Loss: ₹900
Analysis:
SAI Life Sciences is a lesser-tracked pharma contract research & manufacturing company, now gaining traction after Jefferies initiated coverage with a bullish stance. Its unique positioning in R&D outsourcing, coupled with strong global demand for biotech partnerships, makes it an interesting short-term as well as medium-term play.
Technical Setup:
- The stock is trading above its 200-day EMA, confirming strength.
- Breakout above ₹950 can push the stock toward ₹1,050 in the near term.
- Stop-loss remains tight at ₹900.
Outlook: Ideal for traders looking at fresh breakout plays in the pharma outsourcing segment.
🔹 4. Uno Minda
- CMP: ₹1,275
- Target: ₹1,330
- Stop-Loss: ₹1,219
Analysis:
Uno Minda has been riding the strong auto ancillary cycle with increased EV adoption, premiumization, and OEM partnerships. The company’s expansion into new technology components also adds to growth visibility.
Technical Setup:
- The stock recently bounced from ₹1,220 support zone.
- Bullish candles on daily charts with rising volume suggest momentum building up.
- Targets between ₹1,310–1,330 look achievable within the week.
Outlook: Short-term buy candidate with low downside risk and high probability breakout above ₹1,300.
🔹 5. Lupin
- CMP: ₹1,982
- Target: ₹2,050
- Stop-Loss: ₹1,924
Analysis:
Lupin continues its strong run after consistent product launches and regulatory clearances in the US market. Pharma majors are back in focus, and Lupin’s technical setup looks encouraging for a continuation rally.
Technical Setup:
- After consolidating around ₹1,950, the stock is showing higher highs and higher lows.
- RSI at 58 indicates strength without being overbought.
- Resistance placed at ₹2,050; breakout above this could take it higher.
Outlook: Good intra-week candidate for a move toward ₹2,050–2,100.
🔹 6. Mazagon Dock Shipbuilders (MAZDOCK)
- CMP: ₹2,745
- Target: ₹2,875
- Stop-Loss: ₹2,690
Analysis:
Defence sector continues to remain in strong demand with order flows, government push, and budgetary support. Mazdock, being a key shipbuilding PSU, remains a strong momentum stock for traders.
Technical Setup:
- Weekly charts show a breakout continuation pattern.
- If sustained above ₹2,750, the stock could rally to ₹2,875.
- SL at ₹2,690 ensures controlled risk.
Outlook: Defence remains a multi-year growth story, and traders can benefit from the ongoing breakout this week.
🔹 7. Breakout Momentum Picks (Bagadia)
These mid-cap stocks are recommended based on momentum and breakout patterns spotted by analyst Bagadia:
✅ KRN Heat Exchanger
- CMP: ₹954
- Target: ₹1,020
- SL: ₹920
Technical breakout candidate with higher volumes.
✅ Avantel
- CMP: ₹149.7
- Target: ₹160
- SL: ₹144
Defence-tech company; riding satellite communication and R&D demand.
✅ Shaily Engineering
- CMP: ₹2,103
- Target: ₹2,280
- SL: ₹2,050
Plastic engineering leader; multi-week breakout suggests more upside.
✅ Datamatics
- CMP: ₹980
- Target: ₹1,050
- SL: ₹945
IT automation play; short-term bullish channel intact.
✅ Fedbank Financial Services
- CMP: ₹142
- Target: ₹153.5
- SL: ₹137.5
NBFC midcap in breakout zone; volumes support rally continuation.
📊 Sectoral View
- Pharma & Specialty Chemicals: With multiple brokerage upgrades and global demand support, pharma remains a key short-term and positional theme this week. Stocks like Divi’s, Lupin, Cohance, SAI Life are prime beneficiaries.
- Defence: The momentum in Mazdock and Avantel highlights government-led capex focus.
- Auto Ancillaries: Uno Minda remains a structural story backed by EV adoption.
- Midcap Breakouts: Bagadia’s picks (Datamatics, Shaily, Fedbank Fin) show momentum-led setups for traders.
📌 Risk Management
While the setups look strong, traders must stick to defined stop-loss levels to protect capital. Midcap breakouts, especially, tend to be volatile. Position sizing and discipline remain key to maximizing returns in the short term.
🏆 Conclusion
The week starting 25th August 2025 offers a balanced mix of pharma, defence, auto, and midcap breakout plays. With strong institutional upgrades in pharma and technical momentum across midcaps, traders have multiple opportunities to capture short-term gains.
Keeping an eye on global cues, USD-INR moves, and FII flows will further help fine-tune positions.
For disciplined traders, this basket of intra-week buy calls can deliver attractive returns with limited downside risk.
📌 For daily trade setups, technical learning, and smart investing tips, stay tuned to CapitalKeeper.in
📌 For more real-time updates, trade setups, and investment insights — follow us on [Telegram] and [WhatsApp Channel] subscribe to our newsletter!
Subscribe Now , Join Telegram the Crypto Capital Club, Get Free Crypto Updates
📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.By using this website, you agree to the terms of this disclaimer.
Ranjit Sahoo
Founder & Chief Editor – CapitalKeeper.in
Ranjit Sahoo is the visionary behind CapitalKeeper.in, a leading platform for real-time market insights, technical analysis, and investment strategies. With a strong focus on Nifty, Bank Nifty, sector trends, and commodities, she delivers in-depth research that helps traders and investors make informed decisions.
Passionate about financial literacy, Ranjit blends technical precision with market storytelling, ensuring even complex concepts are accessible to readers of all levels. Her work covers pre-market analysis, intraday strategies, thematic investing, and long-term portfolio trends.
When he’s not decoding charts, Ranjit enjoys exploring coastal getaways and keeping an eye on emerging business themes.
📌 Follow Ranjit on:
LinkedIn | Twitter/X | Instagram | ✉️ contact@capitalkeeper.in